Acetaminophen induced hepatotoxicity in Wistar rats - A proteomic approach

Molecules

Volumn 21, Issue 2, 2016, Pages

  Ilavenil, Soundharrajan ^a   Al Dhabi, Naif Abdullah ^b   Srigopalram, Srisesharam ^a   Kim, Young Ock ^a   Agastian, Paul ^c   Baru, Rajasekhar ^d   Choi, Ki Choon ^a   Arasu, Mariadhas Valan ^b  

^a National Institute of Animal Science   (South Korea)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c LOYOLA COLLEGE   (India)

^d DR REDDY'S LABORATORIES LTD   (India)

Author keywords

Acetaminophen; Liver injury; MALDI TOF; Plasma biochemical markers

Indexed keywords

PARACETAMOL; PROTEOME;

ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; LIVER; MALE; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; OXIDATIVE STRESS; PROCEDURES; PROTEOMICS; RAT; SOFTWARE; TOXIC HEPATITIS; TOXICITY TESTING; WISTAR RAT;

ACETAMINOPHEN; ANIMALS; CHEMICAL AND DRUG INDUCED LIVER INJURY; GENE EXPRESSION REGULATION; LIVER; MALE; OXIDATIVE STRESS; PROTEOME; PROTEOMICS; RATS; RATS, WISTAR; SOFTWARE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TOXICITY TESTS, ACUTE;

EID: 84963699995     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21020161     Document Type: Article

References (22)

1. Boutis, K.; Shannon, M. Nephrotoxicity after acute severe acetaminophen poisoning in adolescents. Clin. Toxicol. 2001, 39, 441-445. [CrossRef]
2. Davidson, D.G.; Eastham, W.N. Acute liver necrosis following overdose of paracetamol. Br. Med. J. 1996, 5512, 497-499. [CrossRef]
3. Kleinman, J.G.; Breitenfield, R.V.; Roth, D.A. Acute renal failure associated with acetaminophen ingestion:Report of a case and review of the literature. Clin. Nephrol. 1980, 14, 201-205. [PubMed]
4. Mudge, G.H.; Gemborys, M.W.; Duggin, G.G. Covalent binding of metabolites of acetaminophen to kidney protein and depletion of renal glutathione. J. Pharmacol. Exp. Ther. 1978, 206, 218-226.
5. Vidal, B.C.; Bonventre, J.V.; I-Hong Hsu, S. Towards the application of proteomics in renal disease in renal disease. Clin. Sci. 2005, 109, 421-430. [CrossRef] [PubMed]
6. Pixton, K.L.; Deeks, E.D.; Flesch, F.M. Sperm proteome mapping of a patient who experienced failed fertilization at IVF reveals altered expression of at least 20 proteins compared with fertile donors: case report. Hum. Reprod. 2004, 19, 1438-1447. [CrossRef] [PubMed]
7. Baker, M.A.; Witherdin, R.; Hetherington, L. Identification of posttranslational modifications that occur during sperm maturation using difference in two-dimensional gel electrophoresis. Proteomics 2005, 5, 1003-1012. [CrossRef] [PubMed]
8. Naaby-Hansen, S.; Mandal, A.; Wolkowicz, M.J.; Sen, B.; Westbrook, V.A.; Shetty, J.; Coonrod, S.A.; Klotz, K.L.; Kim, Y.H.; Bush, L.A.; et al. CABYR, a novel calcium-binding tyrosine phosphorylation-regulated fibrous sheath protein involved in capacitation. Dev. Biol. 2002, 242, 236-254. [CrossRef] [PubMed]
9. Turner, R.M.; Musse, M.P.; Mandal, A. Molecular genetic analysis of two human sperm fibrous sheath proteins, AKAP4 and AKAP3, in men with dysplasia of the fibrous sheath. J. Androl. 2001, 22, 302-315. [PubMed]
10. Bohring, C.; Krause, W. Immune infertility: towards a better understanding of sperm [auto]-immunity. The value of proteomic analysis. Hum. Reprod. 2003, 18, 915-924. [CrossRef] [PubMed]
11. Nandhini, V.S.; Viji Stella Bai, G. In-vitro phytopharmacological effect and cardio protective activity of Rauvolfia tetraphylla L. South Ind. J. Biol. Sci. 2015, 1, 97-102.
12. Kleiner, D.E.; Brunt, E.M.; van Natta, M.; Behling, C.; Contos, M.J.; Cummings, O.W.; Ferrell, L.D.; Liu, Y.C.; Torbenson, M.S.; Unalp-Arida, A.; et al. Non alcoholic steato hepatitis clinical research network, design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41, 1313-1321. [PubMed]
13. Dorne, J.L.; Skinner, L.; Frampton, G.K.; Spurgeon, D.J.; Ragas, A.M. Human and environmental risk assessment of pharmaceuticals: differences, similarities, lessons from toxicology. Anal. Bioanal. Chem. 2007, 387, 1259-1268. [CrossRef] [PubMed]
14. Burke, W.; Psaty, B.M. Personalized medicine in the era of genomics. JAMA 2007, 298, 1682-1684. [CrossRef] [PubMed]
15. Rajesh, M.G.; Latha, M.S. Protective effect of Glycyrrhiza glabra Linn. on carbon tetrachloride-induced peroxidative damage. Ind. J. Pharmacol. 2004, 36, 284-286.
16. Martin, J.; Smilkstein, M.D.; Gary, L.; Knapp, M.S.; Kenneth, W.; Kulig, M.D.; Barry, H.; Rumack, M.D. Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose. N. Engl. J. Med. 1988, 319, 1557-1562.
17. Corcoran, G.B.; Mitchell, J.R.; Vaishnav, Y.N.; Horning, E.C. Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzo-quinoneimine. Mol. Pharmacol. 1980, 18, 536-542. [PubMed]
18. Dahlin, D.C.; Miwa, G.T.; Lu, A.Y.; Nelson, S.D. N-acetyl-pbenzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc. Natl. Acad. Sci. USA 1984, 81, 1327-1331. [CrossRef] [PubMed]
19. Manautou, J.E.; Emeigh Hart, S.G.; Khairallah, E.A.; Cohen, S.D. Protection against acetaminophen hepatotoxicity by a single dose of clofibrate: effects on selective protein arylation and glutathione depletion. Fundam. Appl. Toxicol. 1996, 29, 229-237. [CrossRef] [PubMed]
20. Rashed, M.S.; Myers, T.G.; Nelson, S.D. Hepatic protein arylation, glutathione depletion, and metabolite profiles of acetaminophen and a non-hepatotoxic regioisomer, 3′-hydroxyacetanilide, in the mouse. Drug Metab. Dispos. 1990, 18, 765-770. [PubMed]
21. Bartolone, J.B.; Birge, R.B.; Bulera, S.J.; Bruno, M.K.; Nishanian, E.V.; Cohen, S.D.; Khairallah, E.A. Purification, antibody production, and partial amino acid sequence of the 58-kDa acetaminophen-binding liver proteins. Toxicol. Appl. Pharmacol. 1992, 113, 19-29. [CrossRef]
22. Bulera, S.J.; Birge, R.B.; Cohen, S.D.; Khairallah, E.A. Identification of the mouse liver 44-kDa acetaminophen-binding protein as a subunit of glutamine synthetase. Toxicol. Appl. Pharmacol. 1995, 134, 313-320. [CrossRef] [PubMed]